• Eric Daniel Tenda, Mira Yulianti, Moses Mazmur Asaf, Reyhan Eddy Yunus, Wita Septiyanti, Vally Wulani, Ceva Wicaksono Pitoyo, Cleopas Martin Rumende, and Siti Setiati.
• Division of Respirology and Critical Care, Departement of Internal Medicine, Faculty of Medicine Universitas Indonesia. Dr Cipto Mangunkusumo National General Hospital. Imperial College London. ericdanieltenda@yahoo.com.
• Acta Med Indones. 2020 Jan 1; 52 (1): 68-73.

AbstractThe coronavirus disease 2019 (COVID-19) is a highly transmissible acute respiratory disease that is caused by the Severe Acute Respiratory Syndrome CoronaVirus-2 (SARS-CoV-2), a beta coronavirus first discovered in Wuhan, China, in late 2019. COVID-19 has been spreading swiftly globally, and as of March 2020, has been officially declared a pandemic by the World Health Organization (WHO). One of the challenges in managing COVID-19 is the identification of a swift, accessible, and reliable diagnostic modality that could serve as an alternative to a reverse-transcriptase polymerase chain reaction (RT-PCR). As of the writing of this paper, RT-PCR is still the recommended tool in diagnosing COVID-19, but the notion of a more prompt and accurate diagnostic tool is a possibility worth looking into. The objective of this case study is to investigate the importance and utility of chest computed tomography (CT) in the diagnosis of COVID-19, as increasing pieces of evidence suggest that chest CT could prove useful in the clinical pathway in diagnosing COVID-19.

15 keywords...

hide…